Clinical Trial Update: Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BT5528-100 (Phase 1/2) in EphA2-expressing advanced solid tumors. The study includes urothelial carcinoma, ovarian cancer, non-small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Triple-negative Breast Cancer
• Urothelial Carcinoma

Drugs mentioned

• BT5528 (BT5528)

Snippet

Sponsor: BicycleTx Limited | Conditions: Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING